خانه › سرطان پستان › اوهایو › Cleveland
آزمایشهای بالینی سرطان پستان در Cleveland، OH
35 مطالعه برای سرطان پستان در مراکز Cleveland (در شعاع حدود ۳۰ مایل) در جستجوی شرکتکننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
در حال جذب شرکتکنندهمرحله 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
در حال جذب شرکتکنندهمرحله 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of AVZO-021 in Patients With Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1/2
- Avenzo Therapeutics Recruiting Site, Cleveland
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
در حال جذب شرکتکنندهمرحله 3
- Research Site, Cleveland
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1/2
- Cleveland Clinic, Cleveland
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
در حال جذب شرکتکننده
- Cleveland Clinic, Cleveland
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
در حال جذب شرکتکنندهمرحله 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 مایل فاصله
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
در حال جذب شرکتکنندهمرحله 1/2
- UH Cleveland Medical Center, Cleveland
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
در حال جذب شرکتکنندهمرحله 3
- MetroHealth, Cleveland
- Cleveland Clinic, Cleveland
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
در حال جذب شرکتکننده
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
در حال جذب شرکتکنندهمرحله 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
در حال جذب شرکتکنندهمرحله 1
- Cleveland Clinic Foundation, Cleveland
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
در حال جذب شرکتکنندهمرحله 3
- Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital, Mayfield Heights · 12 مایل فاصله
The Vanguard Study: Testing a New Way to Screen for Cancer
در حال جذب شرکتکنندهپذیرش داوطلبان سالم
- Louis Stokes Cleveland VA Medical Center, Cleveland
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
در حال جذب شرکتکنندهمرحله 3
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- South Pointe Hospital, Warrensville Heights · 9 مایل فاصله
- و 1 مورد دیگر
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
در حال جذب شرکتکنندهمرحله 3
- Cleveland Clinic, Cleveland
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
در حال جذب شرکتکنندهمرحله 1
- Cleveland Clinic, Cleveland
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1
- Cleveland Clinic Taussig Cancer Institute, Cleveland
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
در حال جذب شرکتکنندهمرحله 2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
در حال جذب شرکتکنندهمرحله 2
- Case Western Reserve University, Cleveland
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
در حال جذب شرکتکننده
- Case Western Reserve University/University Hospitals Cleveland, Cleveland
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
در حال جذب شرکتکنندهمرحله 1
- UHCMC Seidman Cancer Center, Cleveland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1/2
- UH Cleveland Medical Center, Cleveland
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
در حال جذب شرکتکنندهمرحله 3
- University Hospitals Seidman Cancer Center, Cleveland
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
در حال جذب شرکتکنندهمرحله 2
- Cleveland Clinic, Cleveland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
در حال جذب شرکتکنندهمرحله 2
- Cleveland Clinic, Cleveland
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
در حال جذب شرکتکنندهمرحله 3
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- و 3 مورد دیگر
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
در حال جذب شرکتکنندهمرحله 1/2
- Cleveland Clinic, Cleveland
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
در حال جذب شرکتکنندهمطالعه مشاهدهای
- University Hospitals Seidman Cancer Center, Cleveland
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
در حال جذب شرکتکنندهمطالعه مشاهدهای
- Cleveland Clinic Main Campus, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
در حال جذب شرکتکنندهمطالعه مشاهدهایپذیرش داوطلبان سالم
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکتکنندهمطالعه مشاهدهای
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 مایل فاصله
The Cancer of the Pancreas Screening-5 CAPS5)Study
در حال جذب شرکتکنندهمرحله 3
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
در حال جذب شرکتکنندهمرحله 3
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- و 3 مورد دیگر
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1
- Exelixis Clinical Site #7, Cleveland
آزمایشهای سرطان پستان در سایر شهرها
- New York City, NY134 مطالعه
- Houston, TX126 مطالعه
- Boston, MA111 مطالعه
- Nashville, TN80 مطالعه
- Los Angeles, CA72 مطالعه
- Edison, NJ68 مطالعه
- St. Louis, MO64 مطالعه
- Durham, NC63 مطالعه
- Queens, NY63 مطالعه
- Chicago, IL58 مطالعه
- Philadelphia, PA56 مطالعه
- Dallas, TX55 مطالعه
سایر مطالعات در Cleveland
- سرطان ریه غیرسلول کوچک43 مطالعه
- سرطان (همه انواع)36 مطالعه
- سرطان پروستات34 مطالعه
- نارسایی قلبی33 مطالعه
- سرطان متاستاتیک30 مطالعه
- سرطان تخمدان30 مطالعه
- سرطان ریه26 مطالعه
- سرطان کولورکتال24 مطالعه
- بیماری قلبی-عروقی22 مطالعه
- سرطان آندومتر20 مطالعه
- لوکمیه حاد میلویید20 مطالعه
- بیماری کرون19 مطالعه
از ClinicalTrials.gov، دادهها در تاریخ 5 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم میگیرد چه کسانی میتوانند شرکت کنند.